Jupiter Research Capital (Asia) Ltd’s Relay Therapeutics RLAY Stock Holding History
Bought
Maintained
Sold
Other funds holding RLAY
Jupiter Research Capital (Asia) Ltd's RLAY Position: Q3 2026 in Review
Jupiter Research Capital (Asia) Ltd increased its Relay Therapeutics (RLAY) stake by 22% in Q3 2026, buying an estimated $47K and bringing the position to 13,407 shares worth $242K. The position accounts for 0.03% of the portfolio, ranked #549.
Jupiter Research Capital (Asia) Ltd first reported a position in RLAY in Q4 2025 and has held it in 4 quarters since. 250 funds tracked by Wall St. Rank hold RLAY as of Q3 2026.
- Jupiter Research Capital (Asia) Ltd held 13,407 shares of Relay Therapeutics worth $242K as of Q3 2026.
- Jupiter Research Capital (Asia) Ltd bought 2,454 Relay Therapeutics shares in Q3 2026, an estimated $47K.
- Relay Therapeutics made up 0.03% of Jupiter Research Capital (Asia) Ltd's portfolio in Q3 2026, its #549 holding.
- Jupiter Research Capital (Asia) Ltd first reported a position in Relay Therapeutics in Q4 2025 and has held it in 4 quarters since.
- 250 funds tracked by Wall St. Rank held Relay Therapeutics as of Q3 2026.
Based on Jupiter Research Capital (Asia) Ltd's 13F filing for Q3 2026, filed 16 Nov 2026.